Spotlight on Early-Career researchers a Neuronet interview with Ilja Saris
In this Neuronet spotlight on early-career researcher interview, we speak with Ilja Saris who works
PRISM
The most objective measure of your sociabilty? It’s in your pocket
PRISM is in talks with the EMA on the use of data from smartphones and
Neuronet convenes 6th meeting of its Scientific Coordination Board
On 22 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened
Spotlight on early-career researchers: a Neuronet interview with Lianne Reus
Interview with Lianne Reus, PhD candidate at Amsterdam UMC focusing on social withdrawal in schizophrenia, depression and the early stage of AD.
Neuronet Scientific Coordination Board meeting brings together project leaders in The Hague
On 23 October (The Hague, Netherlands), Neuronet (Efficiently Networking European Neurodegeneration Research) convened the second
Neuronet campaign launches on social media – Why we do what we do
Neuronet’s communication team and our community of communication representatives are pleased to announce that we will celebrate our projects.
PRISM project launches videos
In this series of six videos, you’ll discover more about PRISM and its aims! Precision medicine comes to Neurosymptomatics.
Neuronet Scientific Coordination Board meeting brings together project leaders
Neuronet’s high-level, overarching Scientific Coordination Board is formed by 15 leaders of Innovative Medicines Initiative projects focussed on neurodegeneration.
How the digital revolution is transforming EU-funded brain research
Two Innovative Medicines Initiative neurodegeneration projects are featured in the CORDIS brochure on how the
Scientists unveil plans to identify common social and cognitive elements in patients with Alzheimer’s disease, Depression, Schizophrenia
6 March 2019: European scientists have mapped out a potentially radical new way to identify